"Le Pôle Santé République a accueilli en 2021 plus de 38 000 patients au sein de sa structure et reçu près de 20 000 passages aux urgences. La clinique dispose de 274 lits et places pour des activités médicales, chirurgicales et médico-chirurgicales. Au sein du Pôle Santé République, notre objectif est d'accompagner chaque patient pour une prise en charge globale et personnalisée avant, pendant et après son hospitalisation. De nombreuses spécialités se côtoient au sein de l'établissement : _ angiologie et médecine vasculaire _ cardiologie médicale et interventionnelle _ chirurgie esthétique, réparatrice et reconstructrice _ chirurgie dentaire _ chirurgie digestive et viscérale _ chirurgie maxillo-faciale et stomatologie _ chirurgie ORL"

During the past decade, Pole Sante Republique conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pole Sante Republique" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "The Lymphoma Academic Research Organisation" with 4 trials sponsored, "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pole Sante Republique" #1 collaborator was "CardiaBase" with 1 trials as a collaborator, "Celgene Corporation" with 1 trials as a collaborator, "Centre Henri Becquerel" with 1 trials as a collaborator, "Covance" with 1 trials as a collaborator and "Dana-Farber Cancer Institute" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Pole Sante Republique" are "Breast Cancer" (3 trials), "Heart Failure" (2 trials), "Mitral Valve Insufficiency" (2 trials), "Atrial Fibrillation" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Pole Sante Republique" in a lesser frequency.

Most popular intervention types in "Pole Sante Republique" are "Drug" (11 trials), "Device" (4 trials), "Other" (4 trials), "Procedure" (3 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (3 trials), "Trastuzumab" (3 trials), "Lenalidomide" (2 trials), "Aromatase Inhibitors" (1 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pole Sante Republique" are 19 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Pole Sante Republique". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Pole Sante Republique, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Pole Sante Republique, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".